What are the major opportunities in the Sedative-Hypnotic Drugs market? What are the strategies for the Sedative-Hypnotic Drugs market?

For detailed insights on the major opportunities and strategies in the Sedative-Hypnotic Drugs market, Read More

How does the Sedative-Hypnotic Drugs market relate to the overall economy and other similar markets?

For detailed insights on Sedative-Hypnotic Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Sedative-Hypnotic Drugs market growth? SWOT analysis of the Sedative-Hypnotic Drugs market.

For detailed insights on the key dynamics influencing the Sedative-Hypnotic Drugs market growth and SWOT analysis of the Sedative-Hypnotic Drugs industry, Read More

Global Sedative-Hypnotic Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Sedative-Hypnotic Drugs Global Market Report 2025

Name: Sedative-Hypnotic Drugs Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Class (Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By Disease Type (Sleep Disorders, Anesthesia, Pain, Other Disease Types), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sedative-Hypnotic Drugs Market Overview

• Sedative-Hypnotic Drugs market size has reached to $3.57 billion in 2024

• Expected to grow to $5.2 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market

• Market Trend: Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage

• North America was the largest region in 2024.

What Is Covered Under Sedative-Hypnotic Drugs Market?

A sedative-hypnotic drug refers to a chemical substance utilized to alleviate tension and anxiety, promote a sense of calm (sedative effect), or facilitate sleep induction (hypnotic effect). Sedatives or hypnotics act to suppress the limbic system of the brain, which governs emotional and behavioral reactions, as well as the reticular formation, responsible for regulating sleep patterns and overall consciousness.

The main types of sedative-hypnotic drugs include benzodiazepines, barbiturates, antihistamines, nonbenzodiazepine, and others. Benzodiazepines refer to a class of medications that decrease activity in the brain and nervous system and are used to alleviate symptoms of anxiety and insomnia due to their tranquilizing effects on the central nervous system. It can be administered through various routes, including oral, Parenteral, and others, to cure several diseases, such as sleep disorders, Anesthesia, pain, and others. These are sold through various distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others, to several end-users, including hospitals, specialty clinics, home care, and others.

Sedative-Hypnotic Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Sedative-Hypnotic Drugs Market Size 2025 And Growth Rate?

What Is The Sedative-Hypnotic Drugs Market Growth Forecast?

The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.2 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing healthcare infrastructure, rising disposable incomes, rising incidence of lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and expansion of telemedicine services. Major trends in the forecast period include a growing preference for non-benzodiazepine sedative-hypnotic drugs, innovations in drug delivery technologies, increasing focus on personalized medicine, incorporation of digital health tools, and advent of benzodiazepines.

The forecast of 7.8% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Import restrictions could challenge U.S. sleep clinics by raising costs of benzodiazepine alternatives and insomnia treatments sourced from Hungary and Austria, leading to reduced sleep disorder management options and higher neurological care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Sedative-Hypnotic Drugs Market Segmented?

1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes

2) By Route of Administration: Oral, Parenteral, Other Routes of Administration

3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Benzodiazepines: Diazepam, Lorazepam, Alprazolam

2) By Barbiturates: Phenobarbital, Thiopental, Pentobarbital

3) By Antihistamines: Diphenhydramine, Hydroxyzine

4) By Nonbenzodiazepine: Zolpidem, Eszopiclone, Zaleplon

5) By Other Drug Classes: Melatonin Receptor Agonists, Orexin Receptor Antagonists

What Is Driving The Sedative-Hypnotic Drugs Market? Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market

The increased stress levels are expected to propel the growth of the sedative-hypnotic drugs market going forward. Stress levels refer to the mental or emotional exhaustion individuals experience as a result of unavoidable or challenging circumstances. Several driving factors for stress levels include struggling to balance work responsibilities with personal life, inadequate coping mechanisms, and increasing work pressure among employees. Sedative-hypnotic drugs serve as pharmacological agents primarily intended to induce a state of calmness, diminish anxiety levels, and alleviate tension within individuals, often through their tranquilizing effects on the central nervous system. For instance, in December 2022, according to a survey of 2,212 American adults conducted by the American Psychiatric Association, a US-based national medical specialty organization, over 26% (more than one in four) of respondents indicated they expected to encounter increased stress at the beginning of 2023, marking a rise from the 20% reported in the previous year. Therefore, the increased stress levels are driving the growth of the sedative-hypnotic drugs industry.

Who Are The Major Players In The Global Sedative-Hypnotic Drugs Market?

Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

What Are The Key Trends Of The Global Sedative-Hypnotic Drugs Market? Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage

Major companies operating in the sedative-hypnotic drugs market are focusing on expanding their product portfolio by adding products, such as innovative sublingual film, for acute treatment of agitation and to gain a competitive edge in the market. A sublingual film for the acute treatment of agitation refers to a thin, dissolvable film containing medication that is placed under the tongue for rapid absorption into the bloodstream. For instance, in April 2022, BioXcel Therapeutics Inc., a US-based biopharmaceutical company, announced the launch of IGALMI. It is a sublingual film designed for the acute management of agitation linked to schizophrenia or bipolar I or II disorder in adults. It is the first new acute treatment for schizophrenia or bipolar disorder-associated agitation in nearly a decade and represents a differentiated approach to helping patients manage this difficult and debilitating symptom. The approval of IGALMI marks a significant milestone, offering healthcare teams an innovative tool for managing agitation with its rapid onset of action and self-administered film format.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market? Eagle Pharmaceuticals Inc. Bolsters Portfolio With Acacia Pharma Group Plc Acquisition

In June 2022, Eagle Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Acacia Pharma Group plc for an undisclosed amount. Through this acquisition, Eagle Pharmaceuticals expanded its product portfolio by adding two drugs,'BARHEMSYS' and'BYFAVO', as the addition of these two products proliferated their presence in the acute care space. With this acquisition, both companies look forward to strengthening their position in the oncology and hospital spaces by addressing significant unmet clinical needs. Acacia Pharma Group plc is a UK-based pharmaceutical company that is involved in the manufacturing of sedative-hypnotic drugs.

What Is The Regional Outlook For The Global Sedative-Hypnotic Drugs Market?

North America was the largest region in the sedative-hypnotic drugs market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sedative-Hypnotic Drugs Market?

The sedative-hypnotic drugs market consists of sales of tablets, capsules, injectables, and liquid formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Sedative-Hypnotic Drugs Industry?

The sedative-hypnotic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sedative-hypnotic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Sedative-Hypnotic Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.86 billion
Revenue Forecast In 2034	$5.2 billion
Growth Rate	CAGR of 7.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes 2) By Route of Administration: Oral, Parenteral, Other Routes of Administration 3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels 5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments: 1) By Benzodiazepines: Diazepam, Lorazepam, Alprazolam 2) By Barbiturates: Phenobarbital, Thiopental, Pentobarbital 3) By Antihistamines: Diphenhydramine, Hydroxyzine 4) By Nonbenzodiazepine: Zolpidem, Eszopiclone, Zaleplon 5) By Other Drug Classes: Melatonin Receptor Agonists, Orexin Receptor Antagonists
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Sedative-Hypnotic Drugs Market Characteristics

3. Sedative-Hypnotic Drugs Market Trends And Strategies

4. Sedative-Hypnotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sedative-Hypnotic Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Sedative-Hypnotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Sedative-Hypnotic Drugs Market Growth Rate Analysis

5.4. Global Sedative-Hypnotic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Sedative-Hypnotic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Sedative-Hypnotic Drugs Total Addressable Market (TAM)

6. Sedative-Hypnotic Drugs Market Segmentation

6.1. Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Benzodiazepines

Barbiturates

Antihistamines

Nonbenzodiazepine

Other Drug Classes

6.2. Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Routes of Administration

6.3. Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sleep Disorders

Anesthesia

Pain

Other Disease Types

6.4. Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Other Distribution Channels

6.5. Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Homecare

Other End-Users

6.6. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diazepam

Lorazepam

Alprazolam

6.7. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Barbiturates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phenobarbital

Thiopental

Pentobarbital

6.8. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diphenhydramine

Hydroxyzine

6.9. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Nonbenzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Zolpidem

Eszopiclone

Zaleplon

6.10. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Melatonin Receptor Agonists

Orexin Receptor Antagonists

7. Sedative-Hypnotic Drugs Market Regional And Country Analysis

7.1. Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sedative-Hypnotic Drugs Market

8.1. Asia-Pacific Sedative-Hypnotic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sedative-Hypnotic Drugs Market

9.1. China Sedative-Hypnotic Drugs Market Overview

9.2. China Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sedative-Hypnotic Drugs Market

10.1. India Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sedative-Hypnotic Drugs Market

11.1. Japan Sedative-Hypnotic Drugs Market Overview

11.2. Japan Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sedative-Hypnotic Drugs Market

12.1. Australia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sedative-Hypnotic Drugs Market

13.1. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sedative-Hypnotic Drugs Market

14.1. South Korea Sedative-Hypnotic Drugs Market Overview

14.2. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sedative-Hypnotic Drugs Market

15.1. Western Europe Sedative-Hypnotic Drugs Market Overview

15.2. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sedative-Hypnotic Drugs Market

16.1. UK Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sedative-Hypnotic Drugs Market

17.1. Germany Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sedative-Hypnotic Drugs Market

18.1. France Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sedative-Hypnotic Drugs Market

19.1. Italy Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sedative-Hypnotic Drugs Market

20.1. Spain Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sedative-Hypnotic Drugs Market

21.1. Eastern Europe Sedative-Hypnotic Drugs Market Overview

21.2. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sedative-Hypnotic Drugs Market

22.1. Russia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sedative-Hypnotic Drugs Market

23.1. North America Sedative-Hypnotic Drugs Market Overview

23.2. North America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sedative-Hypnotic Drugs Market

24.1. USA Sedative-Hypnotic Drugs Market Overview

24.2. USA Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sedative-Hypnotic Drugs Market

25.1. Canada Sedative-Hypnotic Drugs Market Overview

25.2. Canada Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sedative-Hypnotic Drugs Market

26.1. South America Sedative-Hypnotic Drugs Market Overview

26.2. South America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sedative-Hypnotic Drugs Market

27.1. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sedative-Hypnotic Drugs Market

28.1. Middle East Sedative-Hypnotic Drugs Market Overview

28.2. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sedative-Hypnotic Drugs Market

29.1. Africa Sedative-Hypnotic Drugs Market Overview

29.2. Africa Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sedative-Hypnotic Drugs Market Competitive Landscape And Company Profiles

30.1. Sedative-Hypnotic Drugs Market Competitive Landscape

30.2. Sedative-Hypnotic Drugs Market Company Profiles

30.2.1. Sun Pharmaceutical Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Sedative-Hypnotic Drugs Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Sanofi-Aventis AG

31.3. AstraZeneca Plc

31.4. Abbott Laboratories

31.5. GlaxoSmithKline plc

31.6. Takeda Pharmaceutical Company Limited

31.7. Boehringer Ingelheim International GmbH

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Mylan N.V.

31.10. Fresenius Kabi AG

31.11. Eli Lilly and Co.

31.12. Aurobindo Pharma Limited

31.13. Cipla Inc.

31.14. Dr. Reddy’s Laboratories Ltd.

31.15. Hikma Pharmaceuticals plc

32. Global Sedative-Hypnotic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market

34. Recent Developments In The Sedative-Hypnotic Drugs Market

35. Sedative-Hypnotic Drugs Market High Potential Countries, Segments and Strategies

35.1 Sedative-Hypnotic Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Sedative-Hypnotic Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Sedative-Hypnotic Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Barbiturates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Nonbenzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Sun Pharmaceutical Industries Inc. Financial Performance

Table 82: Pfizer Inc. Financial Performance

Table 83: F. Hoffmann-La Roche Ltd. Financial Performance

Table 84: Merck And Co. Inc. Financial Performance

Table 85: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Barbiturates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Nonbenzodiazepine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Sun Pharmaceutical Industries Inc. Financial Performance

Figure 82: Pfizer Inc. Financial Performance

Figure 83: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 84: Merck And Co. Inc. Financial Performance

Figure 85: Bayer AG Financial Performance

Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route O...

View Report

Dual Contaminant Pipe Global Market Report 2025 – By Material Type (Polyvinyl Chloride, Chlorinated Polyvinyl Chloride, High-Density Polyethylene, Polyvinylidene Fluoride, Other Materials), By Technology (Conventional Du...

View Report

IoT Based Asset Tracking And Monitoring Global Market Report 2025 – By Connectivity Type( Wi-Fi, Bluetooth, Cellular, NB-IoT, LoRa, SigFox, UWB, GNSS, Other Connectivity Types), By Technology( Device Management, Applicat...

View Report

Terminal Tractor Global Market Report 2025 – By Type (Manual, Automated), By Propulsion (Diesel, Compressed Natural Gas (CNG), Hybrid, Electric), By Tonnage (Less Than 50 Ton, 50-100 Ton, Greater Than 100 Ton), By Axle (...

View Report

Anesthetics Global Market Report 2025 – By Type (General Anesthetics, Local Anesthetics), By Route of Administration (Inhalation Anesthesia Drugs, Intravenous Anesthesia Drugs, Topical Anesthesia Drugs), By Application (...

View Report

Pharmaceutical Suppositories Global Market Report 2025 – By Type (Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories, Other Types), By Base (Fatty Base, Water Miscible Bases, Emulsifying Bases), By End-U...

View Report

Bone Densitometer Global Market Report 2025 – By Type (DXA Systems, Peripheral Bone Densitometers, Radiographic Absorptiometry Scanners, Quantitative Ultrasound Scanners), By Application (Osteoporosis & Osteopenia Diagno...

View Report

Frequently Asked Questions

What is the definition of the Sedative-Hypnotic Drugs market?

How will the Sedative-Hypnotic Drugs market drivers and restraints affect the market dynamics? What forces will shape the Sedative-Hypnotic Drugs industry going forward?

The market major growth driver - Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Sedative-Hypnotic Drugs market?

The sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.57 billion in 2024 to $3.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to the expansion of direct-to-consumer advertising, increased stress levels, higher prevalence of sleep disorders, expansion of direct-to-consumer advertising, and aging populations. The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to " $5.2 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing healthcare infrastructure, rising disposable incomes, rising incidence of lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and expansion of telemedicine services. Major trends in the forecast period include a growing preference for non-benzodiazepine sedative-hypnotic drugs, innovations in drug delivery technologies, increasing focus on personalized medicine, incorporation of digital health tools, and advent of benzodiazepines. For further insights on this market, request a sample here

How is the Sedative-Hypnotic Drugs market segmented?

The sedative-hypnotic drugs market covered in this report is segmented –
1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments:
1) By Benzodiazepines: Diazepam, Lorazepam, Alprazolam
2) By Barbiturates: Phenobarbital, Thiopental, Pentobarbital
3) By Antihistamines: Diphenhydramine, Hydroxyzine
4) By Nonbenzodiazepine: Zolpidem, Eszopiclone, Zaleplon
5) By Other Drug Classes: Melatonin Receptor Agonists, Orexin Receptor Antagonists For further insights on this market, request a sample here

Which region has the largest share of the Sedative-Hypnotic Drugs market? What are the other regions covered in the report?

North America was the largest region in the sedative-hypnotic drugs market in 2024. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Sedative-Hypnotic Drugs market?

What are the key trends in the Sedative-Hypnotic Drugs market?

Major trends in this market include Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Sedative-Hypnotic Drugs Global Market Report 2025

Sedative-Hypnotic Drugs Market Overview

What Is Covered Under Sedative-Hypnotic Drugs Market?

What Is The Sedative-Hypnotic Drugs Market Size 2025 And Growth Rate?

What Is The Sedative-Hypnotic Drugs Market Growth Forecast?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Sedative-Hypnotic Drugs Market Segmented?

What Is Driving The Sedative-Hypnotic Drugs Market? Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market

Who Are The Major Players In The Global Sedative-Hypnotic Drugs Market?

What Are The Key Trends Of The Global Sedative-Hypnotic Drugs Market? Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage

What Are Latest Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market? Eagle Pharmaceuticals Inc. Bolsters Portfolio With Acacia Pharma Group Plc Acquisition

What Is The Regional Outlook For The Global Sedative-Hypnotic Drugs Market?

What Defines the Sedative-Hypnotic Drugs Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Sedative-Hypnotic Drugs Industry?

Sedative-Hypnotic Drugs Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions